SoFi, Affirm and William Blair

William Blair initiates coverage of digital finance stocks with an Outperform on SoFi, Affirm
SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the digital finance subsegment of fintech with an Outperform rating on the two stocks.
Fintech Leaders: SoFi and Affirm Shine as William Blair Kicks Off Coverage with Outperform Ratings
With Outperform ratings on both stocks, SoFi Technologies ( NASDAQ:SOFI) and Affirm Holdings ( NASDAQ:AFRM) shares moved higher on Wednesday after William Blair started coverage of the digital finance industry.
William Blair starts SoFi, Affirm with Outperform ratings
William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm
William Blair Initiates Coverage of SoFi Technologies (SOFI) with Outperform Recommendation
Fintel reports that on January 15, 2025, William Blair initiated coverage of SoFi Technologies (NasdaqGS:SOFI) with a Outperform recommendation. Analyst Price Forecast Suggests 25.59% Downside As of December 23,
Affirm, SoFi Initiated At Outperform In Consumer Digital Financing
William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.
SoFi Technologies initiated with an Outperform at William Blair
William Blair analyst Andrew Jeffrey initiated coverage of SoFi Technologies (SOFI) with an Outperform rating and no price target The firm
FNY Investment Advisers LLC Has $33,000 Stake in SoFi Technologies, Inc. (NASDAQ:SOFI)
FNY Investment Advisers LLC raised its position in SoFi Technologies, Inc. (NASDAQ:SOFI – Free Report) by 727.1% during the ...
Finbold | Finance in Bold17h
Is SoFi stock a buy ahead of Q4 earnings?
For long-term investors, SoFi’s ongoing transformation into a diversified financial ecosystem could make it a worthwhile ...
Moderna price target drops, fintech Outperform, FDA hits tobacco
Yahoo Finance's Brad Smith reviews Wednesday's trending stocks on Wealth. Moderna's (MRNA) price target slashed to $38 from ...
TMCnet3d
William Blair Expands Biopharma Investment Banking Group With Senior Hire
"It is my pleasure to welcome Terence to William Blair's Healthcare investment banking practice and its biopharma group," said Steve Tole, head of Healthcare investment bankin at William Blair. "Our ...